| Registered Number:SC656379 |
For the year ended 31 March 2025
Scotland
Unaudited Financial Statements
For the year ended 31 March 2025
Zra Pharma Ltd
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
Zra Pharma Ltd
Abridged Statement of Financial Position
2024
2025
2
| Property, plant and equipment |
3,231
3,687
3,231
3,687
2,426
| Cash and cash equivalents |
2,608
2,608
2,426
| Trade and other payables: amounts falling due within one year |
(2,252)
(2,357)
174
251
Net current assets
| Total assets less current liabilities |
3,482
3,861
| Trade and other payables: amounts falling due after more than one |
| year |
(988)
(988)
2,494
Net assets
2,873
2,494
2,873
2,494
2,873
Shareholders' funds
| For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006 |
| The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each |
| financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and |
| which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable |
| to the company. |
| All the members have consented to the preparation of an Abridged Income Statement and an Abridged Statement of Financial Position for the year ended 31 March 2025 in accordance with Section 444 (2A) of the Companies Act 2006. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| These financial statements were approved and authorised for issue by the Board on 04 November 2024 and were signed by: |
1 of 3
For the year ended 31 March 2025
Zra Pharma Ltd
Abridged Statement of Financial Position Continued
| The notes form part of these financial statements |
2 of 3
For the year ended 31 March 2025
Zra Pharma Ltd
Notes to the Financial Statements
Statutory Information
| Zra Pharma Ltd is a private limited company, limited by shares, domiciled in Scotland, registration number SC656379. |
45 Caltrop Place
Stirling
Stirlingshire
Scotland
FK7 7XS
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| Property, plant |
| and equipment |
3,946
3,946
| Provision for depreciation, |
| amortisation and impairment |
259
456
Charge for year
715
3,231
3,687
| 3. Average number of persons employed |
During the year the average number of employees was 1 (2024 : 1)
3 of 3